Net profit of Supriya Lifescience rose 57.03% to Rs 46.78 crore in the quarter ended December 2024 as against Rs 29.79 crore during the previous quarter ended December 2023. Sales rose 32.54% to Rs 185.65 crore in the quarter ended December 2024 as against Rs 140.07 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 185.65 | 140.07 | 33 |
| OPM % | 35.52 | 29.62 | - |
| PBDT | 67.54 | 44.07 | 53 |
| PBT | 62.58 | 40.11 | 56 |
| NP | 46.78 | 29.79 | 57 |